CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and software solutions, today announced that revenues for the third quarter of fiscal 2009 were $95,147,000, compared to revenues in the third quarter of last year of $100,244,000, a decline of 5%. Revenue results reflected a negative foreign exchange impact of nearly $3 million, compared to the third quarter of fiscal 2008. The results include approximately $2 million of revenue derived from our newly acquired temperature management business, whose assets were acquired from Alsius Corporation in May 2009. Net income for the quarter was $1,490,000, compared to $5,744,000 for the prior-year quarter. Diluted earnings per share were $0.07, compared to $0.27 in the prior-year quarter. Backlog at the end of the third quarter was approximately $9.8 million.
